2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid

Catalog No. :
ACUOGD039
CAS No. :
137401-45-7
Molecular Formula :
C10H17NO6
Molecular Weight :
247.25

IUPAC Name:2-((tert-butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid

2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$83.00Login to see priceIn stockIn stock
100g95%$267.00Login to see priceIn stockIn stock
500g95%$1090.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid
IUPAC Name2-((tert-butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid
MDL No.MFCD09835539
Molecular FormulaC10H17NO6
Molecular Weight247.25
SMILESO=C(O)C(NC(OC(C)(C)C)=O)C(OCC)=O
InChI KeyJLNKUZUBBRTYOA-UHFFFAOYSA-N
SynonymMFCD09835539 | SY032001 | 2-{[(tert-butoxy)carbonyl]amino}-3-ethoxy-3-oxopropanoic acid | 2-(N-BOC-AMINO)MALONIC ACID MONOETHYL ESTER | JLNKUZUBBRTYOA-UHFFFAOYSA-N | GS-4417 | SCHEMBL1731214 | 2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid |
CAS No.137401-45-7
PubChem CID11011022

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUOGD039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACORPG983 route compound structure diagram
    ACORPG983102831-44-7 In Stock
  2. Then
  3. ACUOGD039 route product structure diagram
    ACUOGD039137401-45-7 In Stock
Inquiry

2. ACUOGD039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUOGD039 route product structure diagram
    ACUOGD039137401-45-7 In Stock
Inquiry

Comments (0)